Coleman Mark's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed May 29, 2024
- Accession no.
- 0000950170-24-066175
- Filed
- May 29, 2024
- Trade date
- May 28-29, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $789.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coleman MarkCIK 0001658379 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2024 | Common Stock | SSaleDisposed | −5,249 | $75.21 | −$394,777.29 | 19,848 | Direct | |
| May 29, 2024 | Common Stock | SSaleDisposed | −5,248 | $75.14 | −$394,334.72 | 14,600 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.